Clinical Trials List
2012-12-13 - 2016-10-01
Phase III
Terminated4
-
Trial Applicant
Boehringer Ingelheim
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2025/08/20
Investigators and Locations
The Actual Total Number of Participants Enrolled
0 Completed
Co-Principal Investigator
- Shang-Ju Wu Division of Hematology & Oncology
- MING YAO Division of Hematology & Oncology
- Jih-Luh Tang Division of Hematology & Oncology
- 林建廷 Division of Hematology & Oncology
- - - 未分科
- Sheng-chieh Chou Division of Hematology & Oncology
- Wen-Chien Chou Division of Hematology & Oncology
- 蔡偉 Division of Hematology & Oncology
- 田慧芬 Division of Hematology & Oncology
- 徐思淳 Division of Hematology & Oncology
- - - Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Completed
The Actual Total Number of Participants Enrolled
0 Terminated
The Actual Total Number of Participants Enrolled
0 Completed
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
23 participants
-
Global
660 participants
